Antibiotic prophylaxis in infants and young children with cystic fibrosis: A randomized controlled trial

Journal of Pediatrics

Volumn 140, Issue 3, 2002, Pages 299-305

  Stutman, Harris R ^a,b   Lieberman, Jay M ^a,b   Nussbaum, Eliezer ^a,b   Marks, Melvin I ^a,b  

^a MILLER CHILDREN S HOSPITAL   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; CEFALEXIN; PLACEBO;

ADOLESCENT; ADULT; ANTHROPOMETRIC PARAMETERS; ANTIBIOTIC PROPHYLAXIS; ARTICLE; BACTERIUM CULTURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CYSTIC FIBROSIS; DISEASE COURSE; DOUBLE BLIND PROCEDURE; HUMAN; LONG TERM CARE; LUNG DISEASE; LUNG FUNCTION; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RANDOMIZED CONTROLLED TRIAL; SCHOOL CHILD; SCORING SYSTEM; STAPHYLOCOCCUS AUREUS; THORAX RADIOGRAPHY; TREATMENT OUTCOME;

EID: 0036220978     PISSN: 00223476     EISSN: None     Source Type: Journal    
DOI: 10.1067/mpd.2002.121930     Document Type: Article

References (23)

1. Pulmonary infections in children with cystic fibrosis
2. State of the art: Cystic fibrosis
3. Cystic fibrosis: A review of pulmonary infections and interventions
4. Increased adherence of Staphylococcus aureus from cystic fibrosis lungs to airway epithelial cells
5. Diagnostic accuracy of oropharyngeal cultures in infants and young children with cystic fibrosis
6. Prophylactic antibiotics for cystic fibrosis (Cochrane review)
7. Cystic fibrosis
8. Standardization of lung function testing in children
9. Standardization of spirometry
10. Changes in the normal maximal expiratory flow-volume curve with growth and aging
11. Lower airway inflammation in infants and young children with cystic fibrosis
12. Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation
13. Current understanding of the inflammatory process in cystic fibrosis: Onset and etiology
14. Pathogenesis of the Pseudomonas lung lesion in cystic fibrosis
15. Outcome measures for clinical trials in cystic fibrosis
16. Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis
17. Pulmonary function in infants with cystic fibrosis: The effect of antibiotic treatment
18. Prognosis in cystic fibrosis treated with continuous flucloxacillin from the neonatal period
19. Continuous versus intermittent oral antibiotics in the management of patients with cystic fibrosis
20. Effect of continuous anti-staphylococcal antibiotic treatment in young children with cystic fibrosis
21. Continuous and intermittent antibiotic therapy in cystic fibrosis patients to age four years
22. Pulmonary function and clinical course in patients with cystic fibrosis after pulmonary colonization with Pseudomonas aeruginosa
23. Prognostic implications of initial oropharyngeal bacterial flora in patients with cystic fibrosis diagnosed before the age of two years